The objective of this scoping review is to systematically review the literature on stigma experienced by residents in recovery residences and its impact on substance use recovery outcomes. The review will use the PRISMA-ScR framework to identify studies focused on stigma and recovery in recovery residences published in English within the United States since 2000, including qualitative, quantitative, and mixed-methods studies. Data will be extracted and analyzed thematically to identify gaps in the literature and inform future research and policy development. Preliminary findings suggest that stigma, including labeling and discrimination, significantly hinders recovery by promoting secrecy and withdrawal among residents. Proximity to recovery residences has been shown to reduce community stigma, indicating the potential for better integration and acceptance. This study aims to provide a comprehensive understanding of stigma in recovery residences, its effects on substance use recovery, and recommendations for creating supportive recovery environments. The significance of this study lies in its potential to inform policy, practice, and research, highlighting the need for stigma reduction to improve recovery outcomes in recovery residences. By addressing gaps in the literature, the findings will contribute to developing more effective interventions and supportive environments for individuals recovering from substance use.

The authors have declared no competing interest.

The author(s) received no specific funding for this work.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

No datasets were generated or analyzed during the current study.